Electron-transfer rates and electronic coupling factors for ferrocene groups attached to gold electrodes via oligo(phenylethynyl) “molecular wire” bridges of variable length and structure are reported. Attachment to gold was achieved via thiol groups at the end of the bridge opposite the ferrocene. Bridge structures were designed to promote strong coupling between gold and ferrocene, thereby promoting rapid electron transport over long distances. The effects of bridge length and of substituents on the phenyl rings in the bridge were addressed. Bridges containing between three and six phenylethynyl units were studied, and a “beta” value of 0.36 Å-1 describing the exponential distance dependence of bridge-mediated electron-transfer rates was obtained. The effect on the rates of adding two propoxy groups onto one of the phenyl rings in the bridge was examined and found to be minimal. The standard electron-transfer rate constant of 350 s-1 obtained for the adsorbate with the longest bridge (six phenylethynyl units, corresponding to an electron-transfer distance of approximately 43 Å) corresponds to an electronic coupling factor between ferrocene and gold of approximately 0.7 cm-1. The extrapolated rate constants at very short distances were nearly the same for the conjugated bridge series and for a related monolayer series in which ferrocene groups were linked to gold via aliphatic bridges. The extrapolated rate constants at short distance also agree with a calculated rate constant for the limiting case of adiabatic electron transfer at an electrode.

Axonal degeneration is an important determinant of progressive neurological disability in multiple sclerosis (MS).

No abstract

Modulating T cell function by down-regulating specific genes using RNA interference (RNAi) holds tremendous potential in advancing targeted therapies in many immune-related disorders including cancer, inflammation, autoimmunity, and viral infections. Hematopoietic cells, in general, and primary T lymphocytes, in particular, are notoriously hard to transfect with small interfering RNAs (siRNAs). Herein, we describe a novel strategy to specifically deliver siRNAs to murine CD4(+) T cells using targeted lipid nanoparticles (tLNPs). To increase the efficacy of siRNA delivery, these tLNPs have been formulated with several lipids designed to improve the stability and efficacy of siRNA delivery. The tLNPs were surface-functionalized with anti-CD4 monoclonal antibody to permit delivery of the siRNAs specifically to CD4(+) T lymphocytes. Ex vivo, tLNPs demonstrated specificity by targeting only primary CD4(+) T lymphocytes and no other cell types. Systemic intravenous administration of these particles led to efficient binding and uptake into CD4(+) T lymphocytes in several anatomical sites including the spleen, inguinal lymph nodes, blood, and the bone marrow. Silencing by tLNPs occurs in a subset of circulating and resting CD4(+) T lymphocytes. Interestingly, we show that tLNP internalization and not endosome escape is a fundamental event that takes place as early as 1 h after systemic administration and determines tLNPs' efficacy. Taken together, these results suggest that tLNPs may open new avenues for the manipulation of T cell functionality and may help to establish RNAi as a therapeutic modality in leukocyte-associated diseases.

The unique properties of fullerenes have raised the interest of using them for biomedical applications. Within this framework, the interactions of fullerenes with proteins have been an exciting research target, yet little is known about how native proteins can bind fullerenes, and what is the nature of these interactions. Moreover, though some proteins have been shown to interact with fullerenes, up to date, no crystal structure of such complexes was obtained. Here we report docking studies aimed at examining the interactions of fullerene in two forms (C60 nonsubstituted fullerene and carboxyfullerene) with four proteins that are known to bind fullerene derivatives: HIV protease, fullerene-specific antibody, human serum albumin, and bovine serum albumin. Our work provides docking models with detailed binding pockets information, which closely match available experimental data. We further compare the predicted binding sites using a novel multiple binding site alignment method. A high similarity between the physicochemical properties and surface geometry was found for fullerene's binding sites of HIV protease and the human and bovine serum albumins.